2013
DOI: 10.1016/j.bbrc.2013.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Arginase inhibition reduces interleukin-1β-stimulated vascular smooth muscle cell proliferation by increasing nitric oxide synthase-dependent nitric oxide production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
7
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 32 publications
1
7
0
Order By: Relevance
“…While COX-2 inhibitors have been shown to reduce tumor growth through arginase inhibition (132, 133), administration of diclofenac, a non-steroidal anti-inflammatory drug against COX-2 (134) and phospholipase A 2 (135), was found to cause tumor suppression via a mechanism related to the inhibition of tumor vascularization (136). Although the expression and activity of arginase in the vasculature was not evaluated in this study, it is speculated that the observed tumor suppression is attributable to the inhibition of vascular arginase since this enzyme has been shown to play an important role in the growth of vascular cells (35, 137139). Although the direct link between COX and arginase in vasomotor regulation remains to be determined, the finding of the close association between these two enzymes in tumor-promoted angiogenesis (140) and in alleviating chronic hypertension and improving vascular endothelial function and vasomotor activity (68) may provide new direction and insights into this underdeveloped research area.…”
Section: Cox and Arginase In Vascular Regulationmentioning
confidence: 98%
“…While COX-2 inhibitors have been shown to reduce tumor growth through arginase inhibition (132, 133), administration of diclofenac, a non-steroidal anti-inflammatory drug against COX-2 (134) and phospholipase A 2 (135), was found to cause tumor suppression via a mechanism related to the inhibition of tumor vascularization (136). Although the expression and activity of arginase in the vasculature was not evaluated in this study, it is speculated that the observed tumor suppression is attributable to the inhibition of vascular arginase since this enzyme has been shown to play an important role in the growth of vascular cells (35, 137139). Although the direct link between COX and arginase in vasomotor regulation remains to be determined, the finding of the close association between these two enzymes in tumor-promoted angiogenesis (140) and in alleviating chronic hypertension and improving vascular endothelial function and vasomotor activity (68) may provide new direction and insights into this underdeveloped research area.…”
Section: Cox and Arginase In Vascular Regulationmentioning
confidence: 98%
“…Differentiated phenotype (contractile phenotype) VSMCs do not proliferate or produce inflammatory mediators [1, 3]. In response to injury, VSMCs change their gene expression profile to a differentiated phenotype (synthetic phenotype or inflammatory phenotype), and begin to produce inflammatory mediators which stimulates VSMC proliferation and migration [46]. On the other hand, some inflammatory mediators ultimately activate transcription factors to initiate gene expression pattern changes associated with VSMC phenotypes to a differentiated phenotype [47].…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, smooth muscle cells of human lung tissue express both isoforms [26,55,59]. In general, ARG expression can be modulated in different sites, depending on the stimulus that is applied [7,41,55,60].…”
Section: Methodsmentioning
confidence: 99%